MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-49 Cr | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr | ₹-45 Cr |
What is the latest Cash Flow from Investing Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-49 Cr |
Mar2024 | ₹-141 Cr |
Mar2023 | ₹-259 Cr |
Mar2022 | ₹-84 Cr |
Mar2021 | ₹-45 Cr |
How is Cash Flow from Investing Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-49 Cr | Negative | |
Mar2024 | ₹-141 Cr | Negative | |
Mar2023 | ₹-259 Cr | Negative | |
Mar2022 | ₹-84 Cr | Negative | |
Mar2021 | ₹-45 Cr | - |
Compare Cash Flow from Investing Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,323.9 Cr | -0.1% | -11.5% | 15.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -0.1% |
-11.5% |
15.4% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses